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E-mail address: jiae0831@yamaguchi-u.ac.jp (J.-A.The effects of the sensory neurotransmitter substance P on the expression of tight junction proteins
and on barrier function in human corneal epithelial cells were investigated. The expression of ZO-1,
but not that of occludin or claudin-1, was increased by substance P in a concentration- and time-
dependent manner. This effect was inhibited by the NK-1 receptor antagonist GR82334 and by
KN62, an inhibitor of Ca2+- and calmodulin-dependent protein kinase II. Substance P also increased
the transepithelial electrical resistance of a cell monolayer in a manner sensitive to GR82334. Sub-
stance P may therefore play a role in maintenance of tight junctions in the corneal epithelium.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Neurotrophic keratopathy is characterized by various types of
corneal epithelial disorders that are induced as a result of trigem-
inal nerve palsy [1–3]. The cornea is densely innervated by sensory
nerves that use substance P (SP) as a neurotransmitter [4,5]. Loss of
ocular innervation by the trigeminal nerve results in a reduction in
the SP content of the cornea [6–8]. We have previously shown that
the barrier function of the corneal epithelium is impaired in a rat
model of neurotrophic keratopathy induced by thermocoagulation
of the ophthalmic branch of the trigeminal nerve [9]. SP plays an
important role in maintenance of corneal epithelial integrity in
addition to its function in corneal sensation [7]. Indeed, adminis-
tration of SP together with insulin-like growth factor (IGF)-1 ame-
liorated the impairment in corneal epithelial barrier function in
rats with neurotrophic keratopathy [9]. The biological effects of
SP are mediated by members of the neurokinin (NK) family of G
protein-coupled receptors [10], with the NK-1 receptor having
the highest afﬁnity for SP [11,12]. The NK-1 receptor functions as
an SP receptor in rabbit corneal epithelial cells and participates
in the synergistic enhancement of corneal epithelial migration
induced by SP and IGF-1 [13].chemical Societies. Published by E
growth factor-1; ZO, zonula
Ko).The corneal epithelium serves as a barrier that separates the eye
from the outside environment [14]. Epithelial cells interact with
each other via specialized intercellular junctions known as zonula
occludens or tight junctions. Tight junctions encircle the cells
immediately below the apical surface and are thought to form
the principal barrier to passive movement of ﬂuid, electrolytes,
macromolecules, and cells through the paracellular pathway [14–
16]. Tight junctions are composed of various types of membrane
proteins, including claudin and occludin, as well as membrane-
associated proteins such as zonula occludens (ZO)-1, ZO-2, and
ZO-3 [17–21]. In the cornea, ZO-1 is localized to the superﬁcial
layer of the epithelium [14,15].
We have now examined the effects of SP both on transepithelial
electrical resistance (TER), which reﬂects barrier function, as well
as on the expression of ZO-1, occludin, and claudin-1 in cultured
human corneal epithelial cells.2. Materials and methods
2.1. Antibodies and reagents
Rabbit polyclonal antibodies to ZO-1, to occludin, to claudin-1
or to claudin-7 were obtained from Zymed (Carlsbad, CA), rabbit
polyclonal antibodies to claudin-2 were obtained from Abcam
(Cambridge, UK), and mouse monoclonal antibodies to a-tubulin
were from Sigma (St. Louis, MO). SP and GR82334 were obtained
from Sigma, and KN62 was from Wako (Osaka, Japan).lsevier B.V. All rights reserved.
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Simian virus 40-transformed human corneal epithelial (HCE)
cells [22] were obtained from RIKEN Biosource Center (Tsukuba,
Japan). The cells were maintained under in supplemented hor-
monal epithelial medium (SHEM), which comprises Dulbecco’s
modiﬁed Eagle’s medium (DMEM)-F12 (50:50, v/v) supplemented
with 15% heat-inactivated fetal bovine serum, bovine insulin
(5 lg/ml), cholera toxin (0.1 lg/ml), recombinant human epider-
mal growth factor (10 ng/ml), and gentamicin (40 lg/ml).
2.3. Immunoblot analysis
HCE cells (2  105) were seeded in 60-mm culture dishes and
cultured in SHEM for 1 day. The medium was then changed to
unsupplemented DMEM-F12, and the cells were further incubated
for 24 h alone and then for various times in the presence of various
concentrations of SP. The cells were then washed with phosphate-
buffered saline and lysed in a solution containing 20 mM Tris–HCl
(pH 7.5), 150 mM NaCl, 5 mM EDTA, 2 mM NaF, 2 mM Na3VO4, and
2% SDS. The lysates (equal amounts of protein) were subjected to
SDS–polyacrylamide gel electrophoresis followed by immunoblot
analysis.A
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Fig. 1. Effects of SP on the expression of tight junction components in HCE cells. (A) Cells
(20 lM) for 24 h. Cell lysates were then subjected to immunoblot analysis with antibod
abundance of each tight junction protein was quantiﬁed by scanning of immunoblots sim
are means ± S.E. of values from three separate experiments. ***P < 0.001 (Student’s t-test)
as in A, after which total RNA was isolated from the cells and subjected to RT-PCR analy
abundance of mRNAs for the tight junction proteins was quantiﬁed by scanning of gels si
and are means ± S.E. of values from three separate experiments. *P < 0.05 (Student’s t-te2.4. RT-PCR analysis
The PCR protocol was designed to maintain ampliﬁcation in the
exponential phase. The sequences of the PCR primers (sense and
antisense, respectively) were 50-TGCCATTACACGGTCCTCTG-30 and
50-GGTTCTGCCTCATCATTTCCTC-30 for ZO-1, 50-AGTGTGATAATAGT-
GAGTGCTATCC-30 and 50-TGTCATACCTGTCCATCTTTCTTC-30 for
occludin, 50-TTCTCGCCTTCCTGGGATG-30 and50-CTTGAACGATTCTAT-
TGCCATACC-30 for claudin-1, and 50-CAGCATTGTGACAGCAGTTG-30
and 50-TTGGTAGGCATCGTAGTAGTTG-30 for claudin-2, and 50-TGA-
GA- GCAAGGCTGGGTAC-30 and 50-TGGGAATGAATGTCGAGATACG-30
for claudin-7 and 50-ACCACAGTCCACGCCATCAC-30 and 50-TCCAC-
CACCCTGTTGCTGTA-30 for glyceraldehyde-3-phosphate dehydro-
genase (G3PDH, internal control).
2.5. Immunoﬂuorescence analysis
HCE cells were cultured in 24-well cultures plates. For staining
of ZO-1, the cells were ﬁxed with 100% methanol for 20 min at
room temperature. The cells were then washed with PBS and ex-
posed to a rabbit polyclonal antibodies to ZO-1 and Alexa Fluor
488-conjugated goat antibodies to rabbit IgG, and the cells were
double stained with DAPI.None
SP
Claudin-1Occludin Claudin-2 Claudin-7
None
SP
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were deprived of serum for 24 h and then incubated in the absence or presence of SP
ies to ZO-1, to occludin, to claudin-1, 2, 7 or to a-tubulin (loading control). (B) The
ilar to those shown in A. Data were normalized by the abundance of a-tubulin and
versus the corresponding value for cells incubated without SP. (C) Cells were treated
sis of ZO-1, occludin, claudin-1, 2, 7 and G3PDH (internal control) mRNAs. (D) The
milar to those shown in C. Data were normalized by the abundance of G3PDH mRNA
st) versus the corresponding value for cells incubated without SP.
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Subconﬂuent HCE cells were isolated by exposure to trypsin and
seeded (5  104 cells per 6.5-mm well) in the apical chambers of a
Transwell apparatus (Costar, Cambridge, MA) on ﬁlters with a pore
size of 0.22 lm. The cells were cultured for 4 days with SHEM in
the absence or presence of SP or GR82334, after which electrical
resistance was measured with STX-2 electrodes and an EVOM Volt-
ohmmeter (World Precision Instruments, Sarasota, FL). TER was
calculated from the measured resistance and normalized by the
area of the monolayer. The background value for blank Transwell
ﬁlters was subtracted from the TER of cell monolayers.B
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Fig. 2. Concentration dependence of the up-regulation of ZO-1 by SP in HCE cells. (A)
indicated concentrations of SP for 24 h. Cell lysates were then subjected to immunoblot
was quantiﬁed by scanning of immunoblots similar to that shown in A. Data were nor
separate experiments. **P < 0.01, ***P < 0.001 (Student’s t-test) versus the value for cells in
the presence of the indicated concentrations of SP for 12 h. Total RNA was then isolated f
abundance of ZO-1 mRNA was quantiﬁed by scanning of gels similar to that shown in C
values from three separate experiments. *P < 0.05 (Student’s t-test) versus the value for3. Results
We ﬁrst examined the effects of SP on the expression of the
tight junction components ZO-1, occludin, and claudin-1, 2, 7 at
the protein and mRNA levels in HCE cells by immunoblot and
RT-PCR analyses, respectively (Fig. 1). Incubation of the cells with
SP (20 lM) for 24 h resulted in signiﬁcant increases in the amounts
of ZO-1 protein and mRNA but did not affect the expression of
occludin or claudin-1, 2, 7. The effects of SP on the abundance of
ZO-1 protein and mRNA were concentration dependent, being sig-
niﬁcant at an SP concentration of 20 lM and maximal at 50 lM
(Fig. 2). These effects of SP (20 lM) were also time dependent30 40 50
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analysis with antibodies to ZO-1 or to a-tubulin. (B) The abundance of ZO-1 protein
malized by the abundance of a-tubulin and are means ± S.E. of values from three
cubated without SP. (C) Cells were deprived of serum for 24 h and then incubated in
rom the cells and subjected to RT-PCR analysis of ZO-1 and G3PDH mRNAs. (D) The
. Data were normalized by the abundance of G3PDH mRNA and are means ± S.E. of
cells incubated without SP.
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Fig. 3. Time course of the SP-induced up-regulation of ZO-1 in HCE cells. Cells were deprived of serum for 24 h and then incubated in the absence or presence of SP (20 lM)
for the indicated times. Lysates or total RNA prepared from the cells were subjected to immunoblot analysis of ZO-1 protein (A) or to RT-PCR analysis of ZO-1 mRNA (B),
respectively.
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creased with incubation time even in the absence of SP, they in-
creased to a greater extent in the presence of SP, with this
difference being maximal at 72 h for ZO-1 protein and at 9 h for
ZO-1 mRNA. These results thus showed that SP up-regulated the
expression of ZO-1, but not that of occludin or claudin-1, 2, 7, in
HCE cells.
We next examined whether the effect of SP on ZO-1 expression
might be mediated by the NK-1 receptor with the use of the NK-1
receptor antagonist GR82334. Whereas GR82334 (20 lM) alone
did not affect the abundance of ZO-1 protein or mRNA (Fig. 4), it
completely inhibited the up-regulation of ZO-1 protein and mRNA
by SP (20 lM). Immunoﬂuorescence analysis conﬁrmed that the
up-regulated the expression of ZO-1 by SP and that was indicated
the expression pattern of the interfaces of adjacent HCE cells. These
results thus indicated that the effect of SP on ZO-1 expression is
mediated by the NK-1 receptor.
To investigate the mechanism by which SP increases the
expression of ZO-1 in HCE cells, we examined the effect of KN62,
an inhibitor of Ca2+- and calmodulin-dependent protein kinase
(CaM-PK) II. Whereas KN62 by itself did not affect the abundance
of ZO-1 protein at 1, 5, or 10 lM, it inhibited the stimulatory effect
of SP (20 lM) on ZO-1 expression in a concentration-dependent
manner (Fig. 5). Inhibitors of phospholipase C (U73122) or of pro-
tein kinase C (H89) did not affect the abundance of ZO-1 protein in
the absence or presence of SP (data not shown). These results thus
implicated CaM-PK II in the intracellular signaling that underlies
the up-regulation of ZO-1 by SP.
Finally, we examined whether SP might affect the barrier func-
tion of an HCE cell monolayer. Incubation of cells with SP (20 lM)
for 4 days resulted in a 68% increase in TER compared with that of
control cells (Fig. 6). This effect of SP was completely inhibited by
GR82334 (20 lM), whereas this NK-1 receptor antagonist had no
effect on TER in the absence of SP.
4. Discussion
We have shown that SP up-regulated the expression of ZO-1,
but not that of occludin or claudin-1, in HCE cells. This effect of
SP was both concentration and time dependent, was apparent atboth the mRNA and protein levels, and was mediated by the NK-
1 receptor and CaM-PK II. Furthermore, SP increased the barrier
function of HCE cell monolayers, as revealed by an increase in
TER. These results thus suggest that SP promotes the establishment
and may contribute to maintenance of barrier function in the cor-
neal epithelium.
The trophic functions of SP in the corneal epithelium are well
established [23–25]. The loss of corneal sensation or damage to
the trigeminal nerve thus affects homeostasis of the corneal epi-
thelium. Denervation of the trigeminal nerve results in impairment
of corneal epithelial cell proliferation [26]. Corneal epithelial
migration and wound closure were also delayed in a rat model of
neurotrophic keratopathy induced by thermocoagulation of the tri-
geminal nucleus in the brain [9]. These previous observations sug-
gest that sensory nerves in the cornea contribute to maintenance
and repair of the corneal epithelium. We also previously showed
that substance P and IGF-1 act synergistically to stimulate corneal
epithelial migration in an organ culture model of the rabbit cornea
[27,28]. The barrier function of the corneal epithelium was also de-
creased in the rat model of neurotrophic keratopathy, and this de-
fect was ameliorated by treatment with SP and IGF-1 [9]. We have
now shown that exposure of cultured HCE cells to SP alone resulted
in up-regulation of the tight junction component ZO-1. We did not
previously examine the effect of SP alone (without IGF-1) on the
barrier function of the corneal epithelium in the rat model of neu-
rotrophic keratopathy [9]. Our present results now suggest that SP
might be sufﬁcient for this effect in vivo. Whereas both SP and IGF-
1 may be required for stimulation of corneal epithelial migration,
which is the ﬁrst phase of epithelial wound healing, only substance
P may be required for establishment of barrier function, which is
the ﬁnal phase of epithelial wound healing.
Among the various protein components of tight junctions, ZO-1
plays an important role in the formation of these junctions [29–
31]. ZO-1 is expressed in the superﬁcial cells of the corneal epithe-
lium [14,15], suggesting that it also contributes to the establish-
ment and maintenance of tight junctions in these cells. ZO-1 is a
phosphoprotein [17] that participates in multiple protein–protein
interactions and has been implicated in regulation of tight junction
permeability [32]. The SP-induced up-regulation of ZO-1 in HCE
cells observed in the present study was accompanied by an in-
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Fig. 5. Effect of the CaM-PK II inhibitor KN62 on the up-regulation of ZO-1 by SP in
HCE cells. Cells were deprived of serum for 24 h and then incubated in the absence
or presence of SP (20 lM) or the indicated concentrations of KN62 for 24 h. Cell
lysates were then subjected to immunoblot analysis with antibodies to ZO-1 and to
a-tubulin.
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Fig. 4. Effect of the NK-1 receptor antagonist GR82334 on the SP-induced up-regulation of ZO-1 in HCE cells. (A) Cells were deprived of serum for 24 h and then incubated in
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Fig. 6. Effects of SP and GR82334 on TER of HCE cell monolayers. Cells were
cultured in the absence or presence of SP (20 lM) or GR82334 (20 lM) for 4 days in
a Transwell apparatus, after which TER was determined. Data were corrected for the
background value of blank Transwell ﬁlters and are means ± S.E. of values from
three separate experiments. ***P < 0.001 (Student’s t-test) versus the value for cells
incubated in the absence of SP and GR82334.
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expression of occludin or claudin-1. The stratiﬁed corneal epithe-
lium consists of 5–7 cell layers, with tight junctions being found
in only the superﬁcial layer [14]. Our observation that SP increased
the expression of ZO-1 but not that of occludin or claudin-1 sug-
gests that ZO-1 is an important target for regulation of the forma-
tion or maintenance of tight junctions, at least in HCE cells.
NK-1 is the principal receptor for SP. The synergistic effect of
substance P with IGF-1 on corneal epithelial migration is mediated
by NK-1, but not by NK-2 or NK-3 [13]. We have now shown that
NK-1 mediates the stimulatory effect of SP on barrier function in
HCE cells. NK-1 is a G protein-coupled receptor, the ligation of
which by SP results in activation of adenylate cyclase, and a conse-
quent increase in the intracellular concentration of cyclic AMP, fol-
lowed by an increase in the cytosolic free Ca2+ concentration.
Protein kinase A, protein kinase C, and CaM-PK II have been impli-
cated in SP signal transduction in various tissues. We previously
showed that the synergistic effect of SP together with IGF-1 on
corneal epithelial wound healing is mediated by activation of
phospholipase C, the consequent generation of the second messen-
ger inositol 1,4,5-trisphosphate, and the activation of CaM-PK II
[33]. Our results now suggest that CaM-PK II, but not phospholi-
pase C or protein kinase C, contributes to the up-regulation of
ZO-1 by SP in HCE cells.
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